The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Induction of a CD8+ Cytotoxic T Lymphocyte Response by Cross-priming Requires Cognate CD4+ T Cell Help
Open accessAbstract
Class I–restricted presentation is usually associated with cytoplasmic degradation of cellular proteins and is often considered inaccessible to exogenous antigens. Nonetheless, certain exogenous elements can gain entry into this so-called endogenous pathway by a mechanism termed cross-presentation. This is known to be effective for class I–restricted cytotoxic T lymphocyte (CTL) cross-priming directed against a variety of exogenous tumor, viral, and minor transplantation antigens. The related effect of cross-tolerance can also effectively eliminate responses to selected self components. In both cases, this presentation appears to require the active involvement of a bone marrow–derived antigen presenting cell (APC). Here, we show that CTL induction by cross-priming with cell-associated ovalbumin requires the active involvement of CD4+ helper T cells. Importantly, this CD4+ population is only effective when both the helper and CTL determinants are recognized on the same APC. Moreover, we would argue that the cognitive nature of this event suggests that the CD4+ T cell actively modifies the APC, converting it into an effective stimulator for the successful priming of the CTL precursor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Huang, A. Y. C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., & Levitsky, H. (1994) · Science · doi:10.1126/science.7513904 · Cited by 1,160
Introduction of soluble protein into the class I pathway of antigen processing and presentation
Moore, M. W., Carbone, F. R., & Bevan, M. J. (1988) · Cell · doi:10.1016/s0092-8674(88)91043-4 · Cited by 1,092
Self-citationBevan, M. J. (1976) · The Journal of experimental medicine · doi:10.1084/jem.143.5.1283 · Cited by 956
Mice lacking MHC class II molecules
Cosgrove, D., Gray, D., Dierich, A., Kaufman, J., Lemeur, M., Benoist, C., & Mathis, D. (1991) · Cell · doi:10.1016/0092-8674(91)90448-8 · Cited by 852
Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.239 · Cited by 706
Self-citationConstitutive class I-restricted exogenous presentation of self antigens in vivo.
Kurts, C., Heath, W. R., Carbone, F. R., Allison, J., Miller, J. F., & Kosaka, H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.923 · Cited by 625
Self-citationCardin, R. D., Brooks, J. W., Sarawar, S. R., & Doherty, P. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.863 · Cited by 501
Helper activity is required for the in vivo generation of cytotoxic T lymphocytes
Keene, J.-A., & Forman, J. (1982) · The Journal of Experimental Medicine · doi:10.1084/jem.155.3.768 · Cited by 500
A new foreign policy: MHC class I molecules monitor the outside world
Rock, K. L. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80605-0 · Cited by 403
Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.
Carbone, F. R., & Bevan, M. J. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.2.377 · Cited by 402
Self-citationInduction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells
Buller, R. M. L., Holmes, K. L., Hügin, A., Frederickson, T. N., & Morse, H. C. (1987) · Nature · doi:10.1038/328077a0 · Cited by 300
CD4+ but not CD8+ cells are essential for allorejection.
Krieger, N. R., Yin, D. P., & Fathman, C. G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.2013 · Cited by 299
Role of self-peptides in positively selecting the T-cell repertoire
Nikolić-Z˘ugić, J., & Bevan, M. J. (1990) · Nature · doi:10.1038/344065a0 · Cited by 294
von Herrath, M. G., Yokoyama, M., Dockter, J., Oldstone, M. B., & Whitton, J. L. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1072-1079.1996 · Cited by 279
Induction of Autoimmune Diabetes by Oral Administration of Autoantigen
Blanas, E., Carbone, F. R., Allison, J., Miller, J. F. A. P., & Heath, W. R. (1996) · Science · doi:10.1126/science.274.5293.1707 · Cited by 256
Self-citationMHC Class I–Restricted CTL Responses to Exogenous Antigens
Jondal, M., Schirmbeck, R., & Reimann, J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80255-1 · Cited by 253
Autoimmune diabetes as a consequence of locally produced interleukin-2
Heath, W. R., Allison, J., Hoffmann, M. W., Schönrich, G., Hämmerling, G., Arnold, B., & Miller, J. F. A. P. (1992) · Nature · doi:10.1038/359547a0 · Cited by 236
Self-citationNash, A. A., Jayasuriya, A., Phelan, J., Cobbold, S. P., Waldmann, H., & Prospero, T. (1987) · Journal of General Virology · doi:10.1099/0022-1317-68-3-825 · Cited by 234
Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
Carbone, F. R., & Bevan, M. J. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.3.603 · Cited by 219
Self-citationA fail-safe mechanism for maintaining self-tolerance.
Guerder, S., & Matzinger, P. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.2.553 · Cited by 202
Ahmed, R., Butler, L. D., & Bhatti, L. (1988) · Journal of Virology · doi:10.1128/jvi.62.6.2102-2106.1988 · Cited by 198
Shirai, M., Pendleton, C. D., Ahlers, J., Takeshita, T., Newman, M., & Berzofsky, J. A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.2.549 · Cited by 182
Mitchison, N. A., & O'Malley, C. (1987) · European Journal of Immunology · doi:10.1002/eji.1830171109 · Cited by 154
Macrophages as accessory cells for class I MHC-restricted immune responses
Debrick, J. E., Campbell, P., & Staerz, U. D. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.9.2846 · Cited by 148
H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes.
Gooding, L. R., & Edwards, C. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.3.1258 · Cited by 84
Cooperation between Helper T Cells and Cytotoxic T Lymphocyte Precursors
HUSMANN, L. A., & Bevan, M. J. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb36335.x · Cited by 81
Cassell, D. J., & Forman, J. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb36325.x · Cited by 64
Liu, Y., & Müllbacher, A. (1989) · Immunology and Cell Biology · doi:10.1038/icb.1989.58 · Cited by 28
Cited by
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., & Schadendorf, D. (1998) · Nature Medicine · doi:10.1038/nm0398-328 · Cited by 2,862
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Di Rosa, F., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,342
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Bennett, S. R. M., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., & Heath, W. R. (1998) · Nature · doi:10.1038/30996 · Cited by 2,092
Self-citationAntigen Presentation and T Cell Stimulation by Dendritic Cells
Guermonprez, P., Valladeau, J., Zitvogel, L., Théry, C., & Amigorena, S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064828 · Cited by 1,926
Metadata
- Authors
- Bennett, S. R. M., Carbone, F. R., Karamalis, F., Miller, J. F. A. P., & Heath, W. R.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1997-07-07
- Volume
- 186
- Issue
- 1
- Pages
- 65-70
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2171986697
- Cited by
- 725
- References
- 28
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.